Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.

Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.

Item
http://www.wikidata.org/entity/Q34608555
Gynecomastia in Patients with Prostate Cancer: A Systematic ReviewGynecomastia: Clinical evaluation and managementEfavirenz directly modulates the oestrogen receptor and induces breast cancer cell growthTamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic reviewMultimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen molecules.Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysisTreatment of bicalutamide-induced breast events.Gynecomastia - evaluation and current treatment optionsIndirect androgen doping by oestrogen blockade in sports.Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist.Tamoxifen in men: a review of adverse events.Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines.Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention.Surgical treatment of primary gynecomastia in children and adolescents.The Early Prostate Cancer program: bicalutamide in nonmetastatic prostate cancer.Long-Term Follow-up of Recurrence and Patient Satisfaction After Surgical Treatment of Gynecomastia.Managing Male Mammary Maladies
P2860

Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.

Item
http://www.wikidata.org/entity/Q34608555
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@ast
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@en
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@nl
type
label
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@ast
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@en
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@nl
prefLabel
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@ast
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@en
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@en
P2093
P304
P31
P356
10.1016/J.EURURO.2007.01.031
P407
P433
P478
P577
P698
P921